港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

巨子生物

71.400

+0.1500.21%

成交量：364.43萬

成交額：2.60億

市值：739.70億

市盈率：31.90

高：73.350

開：70.100

低：68.850

收：71.250

資料載入中...

總覽公司新聞公告

【券商聚焦】招銀國際指2月美妝銷售數據顯示國貨品牌於抖音平臺重點發力護膚品類增長強勁

鉅子生物(02367)出現大手賣出7.56萬股，成交價$70.65，涉資534.114萬

阿斯达克财经

港股異動 | 鉅子生物(02367)漲超5% 可復美3·8大促表現優異瑞銀上調公司盈測及目標價

鉅子生物盤中異動股價大漲5.08%報72.350港元

瑞銀：維持鉅子生物“買入”評級上調目標價至82港元

瑞銀：維持鉅子生物(02367)“買入”評級上調目標價至82港元

《大行》瑞銀升鉅子生物(02367.HK)目標價至82元婦女節表現可能超出預期

阿斯达克财经

錦波生物業績逆勢上漲背後：重組膠原蛋白的“上位”與玻尿酸的“退守”

玻尿酸賣不動，華熙生物又拿自己人開刀

鉅子生物03月06日獲主力加倉3825萬元

起底鉅子生物：如何成為市值最高的中國美妝公司？

鉅子生物早盤漲近7%創新高全年業績獲大行唱好

港股異動 | 鉅子生物(02367)漲超6%創新高全年業績獲大行唱好可復美近期預售表現亮眼

鉅子生物盤中異動早盤股價大漲5.24%報68.300港元

鉅子生物03月03日獲主力加倉2538萬元

鉅子生物(02367)出現大手買入15萬股，成交價$64.15，涉資962.25萬

阿斯达克财经

醫美行業洗牌：新勢力崛起，老玩家如何破局？

21世纪经济报道

【券商聚焦】德邦證券維持鉅子生物(02367)“買入”評級指其作為膠原蛋白龍頭有望隨成分熱度持續擴容

鉅子生物早盤漲超6% 股價創新高花旗給予“買入”評級

【港股異動 | 鉅子生物(02367.HK)漲超5% 】鉅子生物(02367.HK)漲超5%，高見63.3港元創上市以來新高。截至發稿，漲5.69%，報63.15港元，成交額1.43億港元。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02367/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02367","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":71.4,"timestamp":1743667696030,"preClose":71.25,"halted":0,"volume":3644322,"delay":0,"floatShares":1036000000,"shares":1036000000,"eps":2.238041466766702,"marketStatus":"休市中","change":0.15,"latestTime":"04-03 16:08:16","open":70.1,"high":73.35,"low":68.85,"amount":260403832,"amplitude":0.063158,"askPrice":71.5,"askSize":7600,"bidPrice":71.4,"bidSize":28400,"shortable":3,"etf":0,"ttmEps":2.1950462439803764,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1743989400000},"marketStatusCode":7,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":71.25,"dividendRate":0.013585,"openAndCloseTimeList":[[1743643800000,1743652800000],[1743656400000,1743667200000]],"volumeRatio":0.6335034764670934,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","floatShares":1036000000,"roa":"21.88%","roe":"35.88%","lyrEps":2.238041,"volumeRatio":0.6335034764670934,"shares":1036000000,"dividePrice":0.97,"high":73.35,"amplitude":0.063158,"preClose":71.25,"low":68.85,"week52Low":35,"pbRate":"9.77","psRate":"12.53","week52High":75.2,"institutionHeld":0,"latestPrice":71.4,"committee":0.577778,"eps":2.238041466766702,"divideRate":0.013585,"volume":3644322,"delay":0,"ttmEps":2.1950462439803764,"open":70.1,"prevYearClose":49.9,"prevWeekClose":68,"prevMonthClose":70.45,"prevQuarterClose":70.45,"fiveDayClose":67.45,"twentyDayClose":70.35,"sixtyDayClose":46.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02367\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519072118","title":"【券商聚焦】招銀國際指2月美妝銷售數據顯示國貨品牌於抖音平臺重點發力 護膚品類增長強勁","url":"https://stock-news.laohu8.com/highlight/detail?id=2519072118","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519072118?lang=zh_tw&edition=fundamental","pubTime":"2025-03-13 13:40","pubTimestamp":1741844452,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，2月美妆销售数据显示国货品牌于抖音平台重点发力，尤其护肤品类增长强劲。38大促中，毛戈平表现亮眼，成功斩获抖音彩妆榜首。2M25累计GMV同比增长10%。其中同比表现出色的有巨子生物、丸美、上海家化、毛戈平；与2024年季度同比增幅相比，丸美、上海家化增速提升显著。该行指，截至3月11日，该行重点关注的美妆股涨幅约47%，其中毛戈平涨88%，巨子生物涨67%，上美股份涨45%，上海家化涨14%，丸美涨8%。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954974","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01318","02367","02145","BK1207","LU2488822045.USD"],"gpt_icon":1},{"id":"2519796410","title":"鉅子生物(02367)出現大手賣出7.56萬股，成交價$70.65，涉資534.114萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2519796410","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519796410?lang=zh_tw&edition=fundamental","pubTime":"2025-03-13 11:59","pubTimestamp":1741838340,"startTime":"0","endTime":"0","summary":"[大手成交]巨子生物(02367)在上午11:59出现大手卖出，成交量为7.56万，成交价为港币$70.65，涉资534.114万。至目前为止，股价跌1.669%，今日最高价为$71.95，而最低价为$70.4，总成交量为215.232万股，总成交金额港币$1.524亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2503136377/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02367","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2518763873","title":"港股異動 | 鉅子生物(02367)漲超5% 可復美3·8大促表現優異 瑞銀上調公司盈測及目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2518763873","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518763873?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 14:06","pubTimestamp":1741673203,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，巨子生物涨超5%，截至发稿，涨5.01%，报72.35港元，成交额3.15亿港元。榜单显示，巨子生物旗下可复美冲进榜单TOP4，同比去年，可复美排名提升9名。瑞银研报指出，随可复美皇牌产品胶原蛋白棒的表现强劲，加上新的“焦点系列”销售在去年下半年胜预期，对公司今年的增长轨迹有信心，初步数据显示在持续进行的妇女节购物节中，可复美品牌表现强劲。该行重申巨子生物“买入”评级，并将其目标价由63.5港元升至82港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0},{"id":"2518630787","title":"鉅子生物盤中異動 股價大漲5.08%報72.350港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518630787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518630787?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 14:04","pubTimestamp":1741673081,"startTime":"0","endTime":"0","summary":"2025年03月11日下午盘14时04分，巨子生物股票出现波动，股价急速拉升5.08%。截至发稿，该股报72.350港元/股，成交量434.403万股，换手率0.42%，振幅7.99%。资金方面，该股资金流入1.43665亿港元，流出1.31516亿港元。巨子生物股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，帝王国际投资、荃信生物-B、腾盛博药-B涨幅较大，振幅较大的相关个股有帝王国际投资、华领医药-B、方达控股，振幅分别为100.00%、17.04%、15.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311140441964102b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311140441964102b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2518753838","title":"瑞銀：維持鉅子生物“買入”評級 上調目標價至82港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518753838","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518753838?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 11:10","pubTimestamp":1741662600,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　瑞银发布研报称，重申巨子生物（02367）“买入”评级，目标价由63.5港元升至82港元。该行称，随可复美（COMFY）皇牌产品胶原蛋白棒的表现强劲，加上新的“焦点系列”销售在去年下半年胜预期，对公司今年的增长轨迹有信心，初步数据显示在持续进行的妇女节购物节中，可复美品牌表现强劲。\n　　该行上调对公司2024年至2026年的盈利预测3%至4%，以反映最新对去年的收入及盈利指引，以及今明两年的收入及盈利预测因为妇女节的强劲表现而变得更高。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：史丽君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-03-11/doc-inepfzsm9815985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367"],"gpt_icon":0},{"id":"2518232758","title":"瑞銀：維持鉅子生物(02367)“買入”評級 上調目標價至82港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518232758","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518232758?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 10:55","pubTimestamp":1741661734,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银发布研报称，重申巨子生物(02367)“买入”评级，目标价由63.5港元升至82港元。该行称，随可复美(COMFY)皇牌产品胶原蛋白棒的表现强劲，加上新的“焦点系列”销售在去年下半年胜预期，对公司今年的增长轨迹有信心，初步数据显示在持续进行的妇女节购物节中，可复美品牌表现强劲。该行上调对公司2024年至2026年的盈利预测3%至4%，以反映最新对去年的收入及盈利指引，以及今明两年的收入及盈利预测因为妇女节的强劲表现而变得更高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0},{"id":"2518191737","title":"《大行》瑞銀升鉅子生物(02367.HK)目標價至82元 婦女節表現可能超出預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2518191737","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518191737?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 09:56","pubTimestamp":1741658160,"startTime":"0","endTime":"0","summary":"瑞银的研究报告指，将巨子生物(02367.HK) 目标价由63.5元升至82元，重申评级“买入”。该行称，随可复美(COMFY)皇牌产品胶原蛋白棒的表现强劲，加上新的“焦点系列”销售在去年下半年胜预期，对公司今年的增长轨迹有信心，初步数据显示在持续进行的妇女节购物节中，可复美品牌表现强劲。该行上调对公司2024年至2026年的盈利预测3%至4%，以反映最新对去年的收入及盈利指引，以及今明两年的收入及盈利预测因为妇女节的强劲表现而变得更高。(vc/a)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-10 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221209170559652_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221209170559652_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1423650/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02367"],"gpt_icon":0},{"id":"2518216972","title":"錦波生物業績逆勢上漲背後：重組膠原蛋白的“上位”與玻尿酸的“退守”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518216972","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518216972?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 16:42","pubTimestamp":1741596120,"startTime":"0","endTime":"0","summary":"2025年3月，北交所“重组胶原蛋白第一股”锦波生物发布2024年业绩快报，以营收14.47亿元、净利润7.33亿元的爆发式增长，再度刷新行业认知。这一成绩不仅使其与传统玻尿酸巨头华熙生物、爱美客等形成“冰火两重天”的对比，更宣告重组胶原蛋白正式站上医美产业变革的C位。　　锦波生物的核心竞争力源于其全球首创的“164.88°三螺旋结构”重组胶原蛋白技术。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-03-10/doc-inepeiip3574276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2488822045.USD","BK1207","02367"],"gpt_icon":0},{"id":"2517488082","title":"玻尿酸賣不動，華熙生物又拿自己人開刀","url":"https://stock-news.laohu8.com/highlight/detail?id=2517488082","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517488082?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 18:48","pubTimestamp":1741344515,"startTime":"0","endTime":"0","summary":"自宣布业绩“爆雷”后，华熙生物又自曝家丑，当众给了自己一刀。近日，一次内部讲话，把华熙生物的“贪腐”问题摆上了台面，公司所有贪腐人员，被要求在3月31日前交代问题并提交辞呈。“主动调整”，似乎给华熙生物连续两年下滑的业绩找了一个不错的理由。2025年，华熙生物还要接着调整。但在业绩下滑的同时，华熙生物的销售费用、管理费却在增长。目前，华熙生物很难被单纯认定为生物医药领域公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/252488","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2517136088","title":"鉅子生物03月06日獲主力加倉3825萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517136088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517136088?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 16:17","pubTimestamp":1741249040,"startTime":"0","endTime":"0","summary":"03月06日, 巨子生物股价涨1.52%，报收70.35元，成交金额3.53亿元，换手率0.49%，振幅3.25%，量比0.95。巨子生物今日主力资金净流入3825万元，上一交易日主力净流入2439万元。该股近5个交易日上涨10.35%，主力资金累计净流入9361万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.10亿元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170250abeb1554&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170250abeb1554&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"2517491865","title":"起底鉅子生物：如何成為市值最高的中國美妝公司？","url":"https://stock-news.laohu8.com/highlight/detail?id=2517491865","media":"钛媒体","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517491865?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 19:27","pubTimestamp":1741174020,"startTime":"0","endTime":"0","summary":"然而，一家名为巨子生物的公司却显得格格不入——它用一款“皮肤吃的胶原蛋白”，不仅净利率站上了40%，撑起股价两年涨了150%，还在持续刷新新高，目前已经成为市值最高的国货美妆企业。内卷不断加剧的周期里，巨子生物，如何就成了为市值最高的中国美妆公司？2024年上半年，其功效性护肤品生产周期仅9-13天，供应链效率碾压同行；财报显示，同期巨子生物净利率接近40%，是上市美妆企业中最高的。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305193005abe97571&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305193005abe97571&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"2517956742","title":"鉅子生物早盤漲近7%創新高 全年業績獲大行唱好","url":"https://stock-news.laohu8.com/highlight/detail?id=2517956742","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517956742?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 11:51","pubTimestamp":1741146660,"startTime":"0","endTime":"0","summary":"　　巨子生物早盘涨超6%，高见69.30港元，创上市以来新高。截至发稿，股价上涨6.78%，现报69.30港元，成交额3.09亿港元。　　大摩此前指出，预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。花旗此前研报表示，经修订后，预计巨子生物2024年收入将同比增52%，净利润同比增40%，与管理层指引增长一致。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-05/doc-inenqpap7846629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2488822045.USD","BK1207","02367"],"gpt_icon":0},{"id":"2517958090","title":"港股異動 | 鉅子生物(02367)漲超6%創新高 全年業績獲大行唱好 可復美近期預售表現亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2517958090","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517958090?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 10:51","pubTimestamp":1741143116,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，巨子生物涨超6%，高见69.3港元创上市以来新高。截至发稿，涨6.32%，报69港元，成交额2.41亿港元。消息面上，2月27日晚，李佳琦直播间开启38大促预售。可复美胶原棒为直播间最热销单品，单品付定金数超9万，胶原桶也首次亮相李佳琦直播间。大摩此前指出，预计公司2024及2025财年的盈利增长，将分别为37%和23%，即将公布的全年业绩或较该行覆盖范围内的其他公司更强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257850.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"2517376909","title":"鉅子生物盤中異動 早盤股價大漲5.24%報68.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517376909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517376909?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 09:38","pubTimestamp":1741138720,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时38分，巨子生物股票出现异动，股价急速拉升5.24%。截至发稿，该股报68.300港元/股，成交量58.9401万股，换手率0.06%，振幅4.31%。资金方面，该股资金流入2455.09万港元，流出1361.26万港元。巨子生物股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，康宁杰瑞制药-B、再鼎医药、科笛-B涨幅较大，振幅较大的相关个股有科笛-B、康宁杰瑞制药-B、腾盛博药-B，振幅分别为7.59%、7.25%、6.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093841989c5ac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093841989c5ac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2516836206","title":"鉅子生物03月03日獲主力加倉2538萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516836206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516836206?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 16:16","pubTimestamp":1740989790,"startTime":"0","endTime":"0","summary":"03月03日, 巨子生物股价涨3.35%，报收64.70元，成交金额3.11亿元，换手率0.47%，振幅5.35%，量比1.28。巨子生物今日主力资金净流入2538万元，连续5日净流入，上一交易日主力净流入621万元。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为33.33%，平均涨幅为2.33%。该股近5个交易日上涨7.71%，主力资金累计净流入5105万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入3106万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165405a25cd3e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165405a25cd3e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2516508741","title":"鉅子生物(02367)出現大手買入15萬股，成交價$64.15，涉資962.25萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2516508741","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516508741?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 14:45","pubTimestamp":1740984300,"startTime":"0","endTime":"0","summary":"[大手成交]巨子生物(02367)在下午02:45出现大手买入，成交量为15万，成交价为港币$64.15，涉资962.25万。至目前为止，股价升2.476%，今日最高价为$65.35，而最低价为$62.0，总成交量为397.05万股，总成交金额港币$2.541亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2503038763/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2514841645","title":"醫美行業洗牌：新勢力崛起，老玩家如何破局？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514841645","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514841645?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 13:30","pubTimestamp":1740634229,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者韩利明上海报道在医美消费疲软、求美者需求变化等因素的共同作用下，医美上市企业各有忧喜。日前，北交所“重组胶原蛋白第一股”锦波生物发布2024年年度业绩快报显示，报告期内实现营业收入14.47亿元，同比增长85.4%；归母净利润7.33亿元，同比增长144.65%；归母扣非净利润7.13亿元，同比增长149.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502273331473289.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273331473289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02367","BK1222","BK1100","09996","BK1574","LU2488822045.USD","BK1583","09997","BK1207"],"gpt_icon":0},{"id":"2514000490","title":"【券商聚焦】德邦證券維持鉅子生物(02367)“買入”評級  指其作為膠原蛋白龍頭 有望隨成分熱度持續擴容","url":"https://stock-news.laohu8.com/highlight/detail?id=2514000490","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514000490?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:02","pubTimestamp":1740556953,"startTime":"0","endTime":"0","summary":"金吾财讯 | 德邦证券发研指，胶原蛋白成分市场仍处于成长期，远未到成熟期，相比于玻尿酸、胜肽等成分仍有较大空间，且当前市场竞争者寡，未来随着珀莱雅、丸美等更多新国货进场可共同做大胶原市场空间，而巨子生物 作为胶原蛋白市场龙头，有望跟随成分热度持续扩容。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953952","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367","161027"],"gpt_icon":0},{"id":"2514912079","title":"鉅子生物早盤漲超6% 股價創新高花旗給予“買入”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2514912079","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514912079?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 11:44","pubTimestamp":1740541440,"startTime":"0","endTime":"0","summary":"　　巨子生物早盘涨超6%，高见63.55港元，创上市以来新高。截至发稿，股价上涨6.36%，报63.55港元，成交额1.60亿港元。给予巨子生物“买入”评级，基于2025年预测市盈率约25倍，将目标价由61港元上调至68.2港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-26/doc-inemurfp9031526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367"],"gpt_icon":0},{"id":"2514757230","title":"【港股異動 | 鉅子生物(02367.HK)漲超5% 】鉅子生物(02367.HK)漲超5%，高見63.3港元創上市以來新高。截至發稿，漲5.69%，報63.15港元，成交額1.43億港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514757230","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514757230?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 11:08","pubTimestamp":1740539309,"startTime":"0","endTime":"0","summary":"巨子生物(02367.HK)涨超5%，高见63.3港元创上市以来新高。截至发稿，涨5.69%，报63.15港元，成交额1.43亿港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26110848392800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2488822045.USD","BK1207","02367"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02367\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"02367","amount":0.5921,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-18","defaultRemindTime":1750123800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-06-18","currency":"CNY","dateTimestamp":1750089600000,"payDate":"2025-08-29"},{"date":"2025-03-26","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盤後","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-19","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-06-17","symbol":"02367","amount":0.97,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-18","defaultRemindTime":1718587800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-18","currency":"HKD","dateTimestamp":1718553600000,"payDate":"2024-07-05"},{"date":"2024-03-25","symbol":"02367","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02367\",market:\"HK\",,,undefined,":[{"executeDate":"2024-06-17","recordDate":"2024-06-18","paymentDate":"2024-07-05","value":0.97,"currency":"HKD"},{"executeDate":"2025-06-17","recordDate":"2025-06-18","paymentDate":"2025-08-29","value":0.5921,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02367\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":18,"updateTime":1743177600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02367\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02367","date":"2025-04-03","current":32.960917,"percent":0.76819,"low":18.546195,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"high":60.214956,"avg":30.40921,"sd":6.612573,"marketCap":72606945600},"quantilePoints":[{"date":"2022-11-04","current":28.694216,"twenty":26.512834,"median":26.542085,"eighty":27.833364,"marketCap":25968654960},{"date":"2022-11-11","current":35.577583,"twenty":27.402937,"median":34.819032,"eighty":37.211633,"marketCap":32485133920},{"date":"2022-11-18","current":30.409033,"twenty":29.071802,"median":32.325114,"eighty":36.373143,"marketCap":27670720360},{"date":"2022-11-25","current":29.089974,"twenty":29.309257,"median":30.328688,"eighty":34.970742,"marketCap":26260437600},{"date":"2022-12-02","current":29.440115,"twenty":28.58665,"median":29.786096,"eighty":33.378719,"marketCap":27035200000},{"date":"2022-12-09","current":33.170723,"twenty":28.69893,"median":30.328688,"eighty":33.541593,"marketCap":30744000000},{"date":"2022-12-16","current":33.617702,"twenty":28.859591,"median":31.890871,"eighty":33.525219,"marketCap":31085600000},{"date":"2022-12-23","current":32.235512,"twenty":29.23003,"median":32.061881,"eighty":33.375102,"marketCap":29816800000},{"date":"2022-12-30","current":35.028223,"twenty":29.440115,"median":32.235512,"eighty":33.644993,"marketCap":32793600000},{"date":"2023-01-06","current":34.259259,"twenty":29.598569,"median":32.356077,"eighty":33.906187,"marketCap":32403200000},{"date":"2023-01-13","current":37.514633,"twenty":29.683286,"median":32.593587,"eighty":35.138095,"marketCap":36160800000},{"date":"2023-01-20","current":39.320225,"twenty":29.767789,"median":33.170723,"eighty":36.075015,"marketCap":37576000000},{"date":"2023-01-27","current":41.405428,"twenty":29.847916,"median":33.242723,"eighty":36.22764,"marketCap":39576800000},{"date":"2023-02-03","current":46.017337,"twenty":30.125824,"median":33.502098,"eighty":37.981351,"marketCap":44212800000},{"date":"2023-02-10","current":48.646066,"twenty":30.280481,"median":33.687805,"eighty":39.317619,"marketCap":46457600000},{"date":"2023-02-17","current":47.305048,"twenty":30.475064,"median":33.964048,"eighty":41.148897,"marketCap":44749600000},{"date":"2023-02-24","current":46.898265,"twenty":30.969524,"median":34.88282,"eighty":44.591745,"marketCap":43822400000},{"date":"2023-03-03","current":48.206405,"twenty":31.89643,"median":35.69024,"eighty":46.759698,"marketCap":45335200000},{"date":"2023-03-17","current":60.214956,"twenty":31.932315,"median":36.041848,"eighty":47.552658,"marketCap":56754400000},{"date":"2023-03-24","current":51.699724,"twenty":32.016899,"median":36.568073,"eighty":48.347792,"marketCap":49288000000},{"date":"2023-03-31","current":40.925047,"twenty":32.156582,"median":37.514633,"eighty":48.347792,"marketCap":46848000000},{"date":"2023-04-06","current":40.652856,"twenty":32.21578,"median":38.432644,"eighty":48.279626,"marketCap":46506400000},{"date":"2023-04-14","current":37.246115,"twenty":32.289273,"median":38.307612,"eighty":48.226605,"marketCap":42651200000},{"date":"2023-04-21","current":33.385259,"twenty":32.343692,"median":38.098031,"eighty":47.893759,"marketCap":38210400000},{"date":"2023-04-28","current":30.285025,"twenty":32.289273,"median":37.591448,"eighty":47.642868,"marketCap":34404000000},{"date":"2023-05-05","current":26.161165,"twenty":31.945964,"median":37.33158,"eighty":47.490756,"marketCap":29768000000},{"date":"2023-05-12","current":30.574645,"twenty":30.692284,"median":36.23263,"eighty":47.274687,"marketCap":34550400000},{"date":"2023-05-19","current":31.711515,"twenty":30.746535,"median":35.923479,"eighty":47.115193,"marketCap":35331200000},{"date":"2023-05-25","current":31.182824,"twenty":30.822604,"median":35.69024,"eighty":46.935066,"marketCap":34599200000},{"date":"2023-06-02","current":32.039153,"twenty":30.742861,"median":35.028223,"eighty":46.759698,"marketCap":35428800000},{"date":"2023-06-09","current":32.262222,"twenty":30.684805,"median":34.15987,"eighty":46.167812,"marketCap":35624000000},{"date":"2023-06-16","current":32.772734,"twenty":30.742861,"median":33.693297,"eighty":45.892894,"marketCap":36014400000},{"date":"2023-06-23","current":31.032471,"twenty":30.757557,"median":33.682729,"eighty":45.395124,"marketCap":33916000000},{"date":"2023-06-30","current":31.360803,"twenty":30.757557,"median":33.502098,"eighty":44.617559,"marketCap":33964800000},{"date":"2023-07-07","current":31.376956,"twenty":30.759705,"median":33.358016,"eighty":44.488487,"marketCap":33916000000},{"date":"2023-07-14","current":31.254408,"twenty":30.81937,"median":33.206723,"eighty":42.385946,"marketCap":34257600000},{"date":"2023-07-21","current":29.61115,"twenty":30.759705,"median":32.931722,"eighty":41.535665,"marketCap":32305600000},{"date":"2023-07-28","current":31.165322,"twenty":30.717545,"median":32.723027,"eighty":41.405428,"marketCap":33964800000},{"date":"2023-08-04","current":32.76763,"twenty":30.739187,"median":32.639512,"eighty":41.393979,"marketCap":35770400000},{"date":"2023-08-11","current":32.773868,"twenty":30.757557,"median":32.603384,"eighty":41.176747,"marketCap":35575200000},{"date":"2023-08-18","current":30.610294,"twenty":30.757557,"median":32.513854,"eighty":41.037499,"marketCap":32988800000},{"date":"2023-08-25","current":31.726668,"twenty":30.759705,"median":32.346784,"eighty":40.925047,"marketCap":34208800000},{"date":"2023-09-01","current":27.573424,"twenty":30.671209,"median":32.32831,"eighty":40.652856,"marketCap":36697600000},{"date":"2023-09-08","current":26.75169,"twenty":30.572064,"median":32.277824,"eighty":40.648282,"marketCap":35184800000},{"date":"2023-09-15","current":25.993592,"twenty":30.285025,"median":32.235512,"eighty":40.62978,"marketCap":34452800000},{"date":"2023-09-22","current":25.737943,"twenty":29.809068,"median":32.045764,"eighty":40.128892,"marketCap":33964800000},{"date":"2023-09-29","current":25.066298,"twenty":29.656075,"median":31.997803,"eighty":39.81665,"marketCap":33135200000},{"date":"2023-10-06","current":25.484582,"twenty":29.406098,"median":31.918666,"eighty":39.533705,"marketCap":33672000000},{"date":"2023-10-13","current":24.08012,"twenty":28.952772,"median":31.841433,"eighty":39.348774,"marketCap":31768800000},{"date":"2023-10-20","current":22.598372,"twenty":28.090884,"median":31.767659,"eighty":39.309801,"marketCap":29768000000},{"date":"2023-10-27","current":22.348635,"twenty":27.619397,"median":31.711663,"eighty":39.282609,"marketCap":29426400000},{"date":"2023-11-03","current":25.394448,"twenty":27.541831,"median":31.642548,"eighty":39.168886,"marketCap":33525600000},{"date":"2023-11-10","current":25.843419,"twenty":27.016595,"median":31.492944,"eighty":38.901953,"marketCap":34111200000},{"date":"2023-11-17","current":25.355932,"twenty":26.744612,"median":31.467436,"eighty":38.544946,"marketCap":33769600000},{"date":"2023-11-24","current":25.803053,"twenty":26.578324,"median":31.402883,"eighty":38.289787,"marketCap":34648000000},{"date":"2023-12-01","current":25.805078,"twenty":26.361375,"median":31.373452,"eighty":38.186355,"marketCap":34794400000},{"date":"2023-12-08","current":23.911147,"twenty":26.187226,"median":31.314709,"eighty":38.124793,"marketCap":32110400000},{"date":"2023-12-15","current":23.015122,"twenty":25.978956,"median":31.279712,"eighty":37.928033,"marketCap":31085600000},{"date":"2023-12-22","current":23.970526,"twenty":25.934891,"median":31.256547,"eighty":37.726838,"marketCap":32354400000},{"date":"2023-12-29","current":25.605578,"twenty":25.922833,"median":31.253927,"eighty":37.637537,"marketCap":34745600000},{"date":"2024-01-05","current":24.881987,"twenty":25.805078,"median":31.237017,"eighty":37.514633,"marketCap":33525600000},{"date":"2024-01-12","current":25.701327,"twenty":25.757517,"median":31.165322,"eighty":37.417045,"marketCap":34648000000},{"date":"2024-01-19","current":24.032983,"twenty":25.700075,"median":31.138965,"eighty":37.246115,"marketCap":32354400000},{"date":"2024-01-26","current":24.563567,"twenty":25.531167,"median":31.049171,"eighty":36.903516,"marketCap":32940000000},{"date":"2024-02-02","current":22.773078,"twenty":25.419215,"median":30.993085,"eighty":36.23263,"marketCap":30500000000},{"date":"2024-02-09","current":24.329361,"twenty":25.355932,"median":30.81937,"eighty":36.207681,"marketCap":32744800000},{"date":"2024-02-16","current":25.846624,"twenty":25.369207,"median":30.758631,"eighty":36.108181,"marketCap":34794400000},{"date":"2024-02-23","current":26.457355,"twenty":25.369207,"median":30.717545,"eighty":35.899805,"marketCap":35428800000},{"date":"2024-03-01","current":26.003824,"twenty":25.387892,"median":30.635655,"eighty":35.803782,"marketCap":34843200000},{"date":"2024-03-08","current":26.210688,"twenty":25.395134,"median":30.572064,"eighty":35.667709,"marketCap":35136000000},{"date":"2024-03-15","current":30.241869,"twenty":25.409765,"median":30.44783,"eighty":35.490153,"marketCap":40504000000},{"date":"2024-03-22","current":31.217759,"twenty":25.435494,"median":30.569793,"eighty":35.18968,"marketCap":41772800000},{"date":"2024-03-28","current":26.416103,"twenty":25.461641,"median":30.551779,"eighty":34.970062,"marketCap":41528800000},{"date":"2024-04-05","current":26.713065,"twenty":25.484582,"median":30.44783,"eighty":34.88282,"marketCap":41968000000},{"date":"2024-04-12","current":27.194611,"twenty":25.506915,"median":30.285025,"eighty":34.259259,"marketCap":42748800000},{"date":"2024-04-19","current":29.268508,"twenty":25.516475,"median":30.168532,"eighty":34.060481,"marketCap":45969600000},{"date":"2024-04-26","current":29.89571,"twenty":25.531167,"median":29.89571,"eighty":33.867614,"marketCap":46896800000},{"date":"2024-05-03","current":31.286129,"twenty":25.569811,"median":29.89571,"eighty":33.72816,"marketCap":49044000000},{"date":"2024-05-10","current":35.317002,"twenty":25.600357,"median":30.150227,"eighty":34.911901,"marketCap":51288800000},{"date":"2024-05-17","current":33.551674,"twenty":25.608792,"median":30.245106,"eighty":35.034138,"marketCap":48653600000},{"date":"2024-05-24","current":33.729665,"twenty":25.66112,"median":30.409033,"eighty":35.021714,"marketCap":48800000000},{"date":"2024-05-31","current":34.458991,"twenty":25.697876,"median":30.512617,"eighty":34.936642,"marketCap":49905929000},{"date":"2024-06-07","current":35.513458,"twenty":25.700826,"median":30.572064,"eighty":35.034138,"marketCap":51369298000},{"date":"2024-06-14","current":33.485895,"twenty":25.715973,"median":30.610294,"eighty":35.023883,"marketCap":48392099000},{"date":"2024-06-21","current":32.121521,"twenty":25.745773,"median":30.694377,"eighty":34.964455,"marketCap":46323198000},{"date":"2024-06-28","current":32.099848,"twenty":25.775731,"median":30.739187,"eighty":34.884174,"marketCap":46272737000},{"date":"2024-07-05","current":29.936022,"twenty":25.803458,"median":30.671209,"eighty":34.879736,"marketCap":43144155000},{"date":"2024-07-12","current":29.087996,"twenty":25.812746,"median":30.592469,"eighty":34.858532,"marketCap":41983552000},{"date":"2024-07-19","current":27.898783,"twenty":25.84406,"median":30.569793,"eighty":34.80307,"marketCap":40267878000},{"date":"2024-07-26","current":27.412372,"twenty":25.847354,"median":30.44783,"eighty":34.722361,"marketCap":39712807000},{"date":"2024-08-02","current":26.870727,"twenty":25.853895,"median":30.347362,"eighty":34.692602,"marketCap":38905431000},{"date":"2024-08-09","current":29.53175,"twenty":25.868681,"median":30.263126,"eighty":34.580226,"marketCap":43043233000},{"date":"2024-08-16","current":27.651468,"twenty":25.880225,"median":30.20526,"eighty":34.54918,"marketCap":40318339000},{"date":"2024-08-23","current":20.295155,"twenty":25.847354,"median":30.132576,"eighty":34.503268,"marketCap":39157736000},{"date":"2024-08-30","current":21.43279,"twenty":25.766624,"median":29.936022,"eighty":34.476088,"marketCap":41630325000},{"date":"2024-09-06","current":20.565575,"twenty":25.695677,"median":29.843348,"eighty":34.445054,"marketCap":39965112000},{"date":"2024-09-13","current":18.849184,"twenty":25.540828,"median":29.786096,"eighty":34.363297,"marketCap":36533764000},{"date":"2024-09-20","current":20.082561,"twenty":25.484582,"median":29.694562,"eighty":34.259259,"marketCap":39157736000},{"date":"2024-09-27","current":24.850231,"twenty":25.394448,"median":29.657792,"eighty":34.060481,"marketCap":48745326000},{"date":"2024-10-04","current":29.382648,"twenty":25.395362,"median":29.624666,"eighty":34.023673,"marketCap":57374157000},{"date":"2024-10-10","current":27.207172,"twenty":25.409765,"median":29.557165,"eighty":33.926357,"marketCap":52782206000},{"date":"2024-10-18","current":27.08831,"twenty":25.435494,"median":29.436062,"eighty":33.784845,"marketCap":52277596000},{"date":"2024-10-25","current":27.691447,"twenty":25.469288,"median":29.344363,"eighty":33.707844,"marketCap":53438199000},{"date":"2024-11-01","current":28.012496,"twenty":25.497982,"median":29.274876,"eighty":33.690002,"marketCap":54094192000},{"date":"2024-11-08","current":29.463901,"twenty":25.512651,"median":29.272452,"eighty":33.684759,"marketCap":56465859000},{"date":"2024-11-15","current":26.265769,"twenty":25.52529,"median":29.194481,"eighty":33.660087,"marketCap":49956390000},{"date":"2024-11-22","current":26.278217,"twenty":25.56015,"median":29.088985,"eighty":33.628618,"marketCap":49956390000},{"date":"2024-11-29","current":26.561468,"twenty":25.595136,"median":29.046664,"eighty":33.578085,"marketCap":50461000000},{"date":"2024-12-06","current":27.316407,"twenty":25.595136,"median":28.89327,"eighty":33.512207,"marketCap":51772986000},{"date":"2024-12-13","current":27.527865,"twenty":25.608792,"median":28.855293,"eighty":33.470601,"marketCap":52126213000},{"date":"2024-12-20","current":27.519045,"twenty":25.66112,"median":28.7635,"eighty":33.433798,"marketCap":51823447000},{"date":"2024-12-27","current":26.95045,"twenty":25.695677,"median":28.729978,"eighty":33.410147,"marketCap":50713305000},{"date":"2025-01-03","current":25.718533,"twenty":25.700075,"median":28.694216,"eighty":33.386493,"marketCap":48442560000},{"date":"2025-01-10","current":26.596222,"twenty":25.605578,"median":28.598093,"eighty":33.385259,"marketCap":49905929000},{"date":"2025-01-17","current":28.4557,"twenty":25.610934,"median":28.581538,"eighty":33.383573,"marketCap":53438199000},{"date":"2025-01-24","current":29.058848,"twenty":25.694577,"median":28.62658,"eighty":33.365541,"marketCap":54912816000},{"date":"2025-01-28","current":30.995109,"twenty":25.696776,"median":28.668851,"eighty":33.362531,"marketCap":58878741600},{"date":"2025-02-07","current":31.279146,"twenty":25.700576,"median":28.706002,"eighty":33.347316,"marketCap":59082122400},{"date":"2025-02-14","current":32.46032,"twenty":25.708209,"median":28.7635,"eighty":33.295849,"marketCap":61166775600},{"date":"2025-02-21","current":32.605291,"twenty":25.726297,"median":28.850334,"eighty":33.213923,"marketCap":61776918000},{"date":"2025-02-28","current":33.709306,"twenty":25.745773,"median":28.875802,"eighty":33.347316,"marketCap":63658190400},{"date":"2025-03-07","current":37.167941,"twenty":25.761386,"median":29.014465,"eighty":33.385999,"marketCap":70471447200},{"date":"2025-03-14","current":37.985438,"twenty":25.781535,"median":29.070262,"eighty":33.525362,"marketCap":72047648400},{"date":"2025-03-21","current":37.329923,"twenty":25.803863,"median":29.089974,"eighty":33.667635,"marketCap":70776518400},{"date":"2025-03-28","current":31.329348,"twenty":25.820414,"median":29.153791,"eighty":33.6911,"marketCap":69149472000},{"date":"2025-04-03","current":32.960917,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"marketCap":72606945600}],"updateTime":1743814406608}}}